Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024195
Filing Date
2024-10-01
Accepted
2024-10-01 16:39:04
Documents
1
Period of Report
2024-09-27

Document Format Files

Seq Description Document Type Size
1 form4-10012024_081000.html 4  
1 form4-10012024_081000.xml 4 4126
  Complete submission text file 0001415889-24-024195.txt   5589
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 241343912

Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)